Bank of America Corp Reports New 5.5% Stake in Treace Medical Concepts, Inc. (TMCI)

On May 14, 2026, Bank of America Corporation filed a Schedule 13G with the SEC, reporting a new ownership stake in Treace Medical Concepts, Inc. (TMCI). As of the event date on March 31, 2026, the financial institution beneficially owns 3,533,774 shares of Common Stock, representing 5.5% of the company's outstanding shares. This filing marks an increase from a previous position of zero, establishing Bank of America as a significant shareholder. The shares are held through several wholly owned subsidiaries, including BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International. The filing indicates that the shares were acquired in the ordinary course of business and are not held with the intent of changing or influencing the control of the issuer. The calculation of the ownership percentage was based on 64,590,503 outstanding shares as reported in the issuer's Form 10-K filed in February 2026. Bank of America reported shared voting and dispositive power over the entire reported share amount.